These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20547640)

  • 21. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The microbiota and infectious diarrhea].
    Surawicz CM
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S29-36. PubMed ID: 20889002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Jul; 41(7):1212-21. PubMed ID: 17595306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired Clostridium difficile NAP1/027-associated diarrhea in an eighteen month old child.
    Quesada-Gómez C; Vargas P; López-Ureña D; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E
    Anaerobe; 2012 Dec; 18(6):581-3. PubMed ID: 23116882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
    Gens KD; Elshaboury RH; Holt JS
    J Pharm Pract; 2013 Oct; 26(5):498-505. PubMed ID: 23966282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy.
    Miller M
    Anaerobe; 2009 Dec; 15(6):281-4. PubMed ID: 19699309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring the severity of Clostridium difficile infection: implications for management and drug development.
    Belmares J; Gerding DN; Tillotson G; Johnson S
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):897-908. PubMed ID: 19053902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile Infection.
    Knight CL; Surawicz CM
    Med Clin North Am; 2013 Jul; 97(4):523-36, ix. PubMed ID: 23809712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile colitis: review of the therapeutic approach.
    Joseph J; Singhal S; Patel GM; Anand S
    Am J Ther; 2014; 21(5):385-94. PubMed ID: 22990077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
    Miller M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile: controversies and approaches to management.
    Bauer MP; van Dissel JT; Kuijper EJ
    Curr Opin Infect Dis; 2009 Dec; 22(6):517-24. PubMed ID: 19738464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012.
    Tvede M; Tinggaard M; Helms M
    Clin Microbiol Infect; 2015 Jan; 21(1):48-53. PubMed ID: 25636927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile infections: emerging epidemiology and new treatments.
    Cohen MB
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S63-5. PubMed ID: 19300129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
    De Leon LM; Watson JB; Kelly CR
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
    Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
    Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.